slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 47,191-47,220
Pages 3,679
Rows per page 30
Component
47,191-47,220 of 110,355
58
This slide functions as a 'villain_critique' or 'expose_contradiction' regarding the drug's clinical reception.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
59
Soleno Therapeutics (SLNO)Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
60
The slide uses direct quotes from an expert to discredit a competitor's clinical trial results.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
61
This slide presents expert testimony/critique from a trial investigator, serving as a 'villain_critique' or 'expose_contradiction' style slide.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
62
The slide uses a 'nominee_bio' structure to present a 'villain_critique' or 'expose_contradiction' narrative.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
63
The slide uses direct quotes to expose potential data omissions and competitive disadvantage.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
64
The slide uses direct quotes from an expert to undermine the commercial viability and clinical efficacy of the drug.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
65
The slide uses direct quotes from a trial investigator to undermine the drug's efficacy and safety profile.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
66
This slide is part of a series of 'investigator' profiles used to build a case against a company's clinical trial results.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
67
The slide presents critical expert feedback on drug formulation and safety protocols.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
68
The slide uses a 'villain' or 'expert critic' framing to undermine the credibility of a clinical trial and its associated drug.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
69
The slide uses direct quotes from an expert to undermine the value proposition of the subject company's product.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
70
The slide uses a series of bullet points to contrast public posturing with private admissions.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
71
The slide uses specific quotes from an investigator to undermine the validity of clinical trial results and highlight potential adverse events.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
73
The slide emphasizes the credibility and breadth of the expert sample to validate the subsequent findings.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
74
The slide uses direct quotes to undermine the credibility of the drug's approval and market demand.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
75
The slide uses direct quotes from an expert consultation to undermine the company's product launch and clinical efficacy claims.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
76
The slide uses a direct quote to highlight medical risks that could limit the drug's market potential.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
77
The slide serves as a negative testimonial/expert critique of the product.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
78
The slide uses direct quotes to highlight a lack of industry awareness and clinical skepticism regarding the drug's mechanism and efficacy.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
79
The slide uses direct quotes to highlight the expert's negative sentiment and lack of awareness/enthusiasm for the drug.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
80
The slide highlights the risk of off-label substitution for the product.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
81
The slide captures qualitative feedback from a medical expert, highlighting low adoption rates and negative sentiment toward the company's sales approach.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
82
The slide uses direct quotes to undermine the company's marketing claims and highlight physician concerns regarding side effects like diabetes.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
83
The slide uses direct quotes from an expert to undermine the company's clinical narrative.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
84
The slide uses direct quotes to undermine the company's marketing claims about drug efficacy and differentiation.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
85
The slide uses direct quotes to highlight the physician's lack of confidence in the drug and his perception of external pressure from patient advocacy groups.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
86
The slide uses direct quotes to undermine the credibility of the drug's clinical narrative and the company's influence on investigators.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
87
The slide uses direct quotes to validate the activist's thesis regarding the drug's risks and market limitations.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
88
The slide highlights the gap between physician prescribing behavior (driven by patient pressure) and their actual clinical belief in the product.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit